Zhicheng Tian

Dr. Zhicheng Tian

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2025 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
PZPeng Zou
Peng Zou
TLTianjing Li
Tianjing Li
ZCZixuan Cao
Zixuan Cao
EYErwan Yang
Erwan Yang
MBMingdong Bao
Mingdong Bao
PLPeng Luo
Peng Luo
Traumatic brain injury (TBI) is one of the leading causes of disability and mortality, which was classified as low-altitude TBI and high-altitude TBI. A large amount of literature shows that high-altitude TBI is associated with more severe neurological impairments and higher mortality rates compared to low-altitude TBI, due to the special environment of high-altitude hypoxia. However, the role of high-altitude hypoxia in the pathogenesis of TBI remains unclear. In order to deeply investigate this scientific issue, we constructed a high-altitude hypoxic TBI model at different altitudes and used animal behavioral assessments (Modified neurological severity score, rotarod test, elevated plus maze test) as well as histopathological analyses (brain gross specimens, brain water content, Evans blue content, hypoxia inducible factor-1α, Hematoxylin-Eosin staining and ROS detection) to reveal its underlying principles and characteristics. We found that with higher altitude, TBI-induced neurological deficits were more severe and the associated histopathological changes were more significant. Single-nuclear RNA sequencing was subsequently employed to further reveal differential gene expression profiles in high-altitude TBI. We found a significant increase in ferroptosis of astrocytes in cases of high-altitude TBI compared to those at low-altitude TBI. Analyzing transcription factors in depth, we found that Bach1 plays a crucial role in regulating key molecules that induce ferroptosis in astrocytes following high-altitude TBI. Down-regulation of Bach1 can effectively alleviate high-altitude TBI-induced neurological deficits and histopathological changes in mice. In conclusion, high-altitude hypoxia may significantly enhance the ferroptosis of astrocytes and aggravate TBI by up-regulating Bach1 expression. Our study provides a theoretical foundation for further understanding of the mechanism of high-altitude hypoxic TBI and targeted intervention therapy.

13 November 2024 in Ageing Research Reviews
Verified
Journal Article
Open access
ZTZhicheng Tian
Zhicheng Tian
QZQi Zhang
Qi Zhang
LWLing Wang
Ling Wang
MLMengxiang Li
Mengxiang Li
TLTianjing Li
Tianjing Li
PLPeng Luo
Peng Luo
Neurodegenerative diseases (NDDs) represent a class of neurological disorders characterized by the progressive degeneration or loss of neurons, impacting millions of individuals globally. In addition to the typical manifestations, pain is a prevalent symptom associated with NDDs, seriously impacting the quality of life for patients. The pathogenesis of pain associated with NDDs is intricate and multifaceted. Currently, the clinical management of NDDs-related pain symptoms predominantly relies on conventional pharmacological agents or physical therapy. However, these approaches often fail to produce satisfactory outcomes. This article summarizes the underlying mechanisms of major NDDs-associated pain: Neuroinflammation, Brain and spinal cord dysfunctions, Mitochondrial dysfunction, Risk gene and pathological protein, as well as Receptor, channel, and neurotransmitter. While numerous studies have investigated the downstream pathological processes associated with these mechanisms, there remains a significant gap in identifying the key initiating factors. Specifically, there is insufficient evidence for the upstream elements that activate microglia and astrocytes in neuroinflammation leading to pain in NDDs. Likewise, there is an absence of upstream factors elucidating how dysfunctions in the brain and spinal cord, as well as mitochondrial impairments, contribute to the development of pain. Furthermore, the specific mechanisms through which hallmark pathological proteins related to NDDs contribute to these pathological processes remain inadequately understood. The objective of this article is to synthesize the existing mechanisms underlying pain associated with NDDs, including Alzheimer's disease, Parkinson's disease, Huntington's disease, Schizophrenia, Amyotrophic lateral sclerosis, and Multiple sclerosis, while also identifying gaps and deficiencies in these mechanisms. This paper offers insights for future research trajectories. Given the intricate pathogenesis of NDDs-related pain, it emphasizes that a promising short-term strategy is combination therapy-intervening concurrently in multiple pathological processes-akin to the cocktail approach utilized in treating acquired immunodeficiency syndrome (AIDS). For long-term advancements, achieving breakthroughs in the treatment of the NDDs themselves will remain essential for alleviating accompanying pain symptoms.

30 October 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
HZHaofuzi Zhang
Haofuzi Zhang
YHYutao Huang
Yutao Huang
EYErwan Yang
Erwan Yang
XGXiangyu Gao
Xiangyu Gao
PZPeng Zou
Peng Zou
XJXiaofan Jiang
Xiaofan Jiang
Background: Glioma is the most common primary tumor of the central nervous system with a high lethality rate. This study aims to mine fibroblast-related genes with prognostic value and construct a corresponding prognostic model. Methods: A glioma-related TCGA (The Cancer Genome Atlas) cohort and a CGGA (Chinese Glioma Genome Atlas) cohort were incorporated into this study. Variance expression profiling was executed via the “limma” R package. The “clusterProfiler” R package was applied to perform a GO (Gene Ontology) analysis. The Kaplan–Meier (K–M) curve, LASSO regression analysis, and Cox analyses were implemented to determine the prognostic genes. A fibroblast-related risk model was created and affirmed by independent cohorts. We derived enriched pathways between the fibroblast-related high- and low-risk subgroups using gene set variation analysis (GSEA). The immune infiltration cell and the stromal cell were calculated using the microenvironment cell populations-counter (MCP-counter) method, and the immunotherapy response was assessed with the SubMap algorithm. The chemotherapy sensitivity was estimated using the “pRRophetic” R package. Results: A total of 93 differentially expressed fibroblast-related genes (DEFRGs) were uncovered in glioma. Seven prognostic genes were filtered out to create a fibroblast-related gene signature in the TCGA-glioma cohort training set. We then affirmed the fibroblast-related risk model via TCGA-glioma cohort and CGGA-glioma cohort testing sets. The Cox regression analysis proved that the fibroblast-related risk score was an independent prognostic predictor in prediction of the overall survival of glioma patients. The fibroblast-related gene signature revealed by the GSEA was applicable to the immune-relevant pathways. The MCP-counter algorithm results pointed to significant distinctions in the tumor microenvironment between fibroblast-related high- and low-risk subgroups. The SubMap analysis proved that the fibroblast-related risk score could predict the clinical sensitivity of immunotherapy. The chemotherapy sensitivity analysis indicated that low-risk patients were more sensitive to multiple chemotherapeutic drugs. Conclusion: Our study identified prognostic fibroblast-related genes and generated a novel risk signature that could evaluate the prognosis of glioma and offer a theoretical basis for clinical glioma therapy.

29 August 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
WHWenchao Hu
Wenchao Hu
FWFutai Wang
Futai Wang
ZNZiyo Niu
Ziyo Niu
PLPeiyang Liu
Peiyang Liu
ZTZhicheng Tian
Zhicheng Tian
RXRou-Gang Xie
Rou-Gang Xie
Background: Peripheral nerve injury drives persistent remodeling of the dorsal root ganglion (DRG) microenvironment, but the cellular states and intercellular signaling mechanisms that sustain neuropathic pain remain poorly understood. Methods: Here, we integrated single-cell transcriptomics with histological, behavioral, and electrophysiological approaches to identify an interferon-responsive state in satellite glial cells (SGCs) of the DRG following spared nerve injury (SNI). Results: This state was distinguished by STAT1-associated interferon-responsive genes’ activation and enhanced chemokine signaling, particularly involving CXCL10 and its receptor CXCR3. These molecular alterations were accompanied by remodeling of intercellular communication among SGCs, sensory neurons, and immune cells. Pharmacological inhibition of STAT1 or blockade of CXCR3 not only reduced sensory-neuron hyperexcitability but also attenuated pain hypersensitivity and improved deficits in hindlimb weight bearing and gait after SNI. Conclusions: Collectively, our findings indicate that interferon-responsive SGCs (IFN SGCs) contribute to the maintenance of neuropathic pain by regulating STAT1-dependent chemokine signaling in the DRG. Targeting this signaling pathway may provide a therapeutic strategy for persistent neuropathic pain.

6 November 2026 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
YJYibin Jia
Yibin Jia
ZCZixuan Cao
Zixuan Cao
HXHanjiang Xue
Hanjiang Xue
ZFZhebin Feng
Zhebin Feng
ZMZhiguo Ma
Zhiguo Ma
PLPeng Luo
Peng Luo
Background: Traumatic brain injury (TBI) induces persistent cognitive deficits, yet conventional biochemical and structural models often fail to explain synaptic signal collapse in the absence of overt tissue rupture. Results: Here, we present a hypothesis‐generating mechanobiological framework that positions postsynaptic density (PSD)—a multivalent protein condensate governed by liquid–liquid phase separation (LLPS)—as a primary locus of synaptic mechanovulnerability. We argue that TBI‐induced synaptic pathology is not merely a quantitative loss of molecular components, but a progressive, staged material state transition of the PSD network. This pathological evolution initiates with hyperacute mechanical deconstruction, leading to physical scaffold decoupling and nanoscale receptor misalignment. It then advances through an acute mechano‐metabolic crisis characterized by enzymatic scaffold cleavage and impaired re‐condensation, ultimately culminating in a chronically locked, low‐dynamic “solidified” state. Furthermore, post‐injury extracellular matrix stiffening and the mechanical exposure of cryptic epitopes trigger aberrant microglial pruning via mechanosensors such as Piezo1, permanently dismantling neural circuits. Because the supporting evidence is heterogeneous, we explicitly grade each element of this model as established directly in TBI, supported in non‐TBI synaptic systems, extrapolated from reconstituted condensates, or hypothetical. Conclusions: By bridging macroscopic biomechanics with nanoscale molecular pathology, this review highlights a critical conceptual gap and proposes “mechano‐therapeutics” as a hypothesis‐generating concept rather than an established treatment avenue. We suggest that strategies targeting the physical properties of the synapse, such as stabilizing scaffold oligomerization, modulating mechanotransduction pathways, and restoring physiological tissue stiffness, are candidate directions whose feasibility, delivery, cell‐type specificity, timing, and safety must first be established in preclinical models before any clinical translation to rescue synaptic homeostasis and cognitive function after TBI.